Загрузка...
LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy
The constitutive activation of signal transducer and activator of transcription 3 (STAT3) is frequently detected in clinical incidences of hepatocellular carcinoma (HCC) but not in normal human hepatocytes. STAT3 signaling plays pivotal roles in angiogenesis, survival, metastasis, and growth of HCC....
Сохранить в:
| Опубликовано в: : | Oncotarget |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Impact Journals LLC
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4484430/ https://ncbi.nlm.nih.gov/pubmed/25883212 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|